CRKL


Summary: This gene encodes a protein kinase containing SH2 and SH3 (src homology) domains which has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. It is a substrate of the BCR-ABL tyrosine kinase, plays a role in fibroblast transformation by BCR-ABL, and may be oncogenic.[provided by RefSeq, Jan 2009].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in CRKL


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP TAS GO:0000186 activation of MAPKK activity
BP IEA GO:0001568 blood vessel development
BP IMP GO:0001933 negative regulation of protein phosphorylation
BP IMP GO:0001934 positive regulation of protein phosphorylation
BP TAS GO:0007254 JNK cascade
BP TAS GO:0007265 Ras protein signal transduction
Showing 1 to 6 of 29 rows rows per page

Gene expression in normal tissue: CRKL

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in CRKL


Loading, please wait...
Database
Pathway ID
Pathway Des.
biocarta at1rpathway angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling
biocarta gleevecpathway inhibition of cellular proliferation by gleevec
biocarta il2rbpathway il-2 receptor beta chain in t cell activation
biocarta integrinpathway integrin signaling pathway
biocarta pyk2pathway links between pyk2 and map kinases
reactome R-HSA-1280215 Cytokine Signaling in Immune system
Showing 1 to 6 of 75 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD61 Kinetin riboside 5
iGMDRD85 Ursolic acid 3
iGMDRD446 LY 2183240 2
iGMDRD945 ML214 3
Showing 1 to 4 of 18 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in CRKL

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​